Pollogen to showcase at World Congress of Dermatology their latest non-surgical technologies that provide a new level of facial and body rejuvenation

Thursday, July 23rd, 2015


(PRWEB) June 02, 2015

Pollogen Ltd. will showcase its latest technologies in their booth (1427) at the World Congress of Dermatology (WCD) in Vancouver, Canada June 9-12. Pollogen proven technologies have set new standards for optimal facial and body contouring, dermal volumizing, wrinkle, scar and cellulite reduction. These new technologies are now found in Pollogen’s latest medical aesthetic devices the Pollogen LEGEND with VoluDerm and the geneO+ with OxyGeneo. Pollogen technologies provide treatments that are non-surgical, results that are immediate and long term, with no discomfort and no downtime.

VoluDerm facial rejuvenation treatment – An optimal combination of fine micro-needles and radio frequency for dermal volumizing, wrinkle reduction, and facial skin contouring with no pain or downtime. A recent study published by Dr. Steven D. Shapiro concluded that VoluDerm treatments demonstrated “significant dermal volume enhancement, reduction of wrinkles including nasolabial folds, perioral and periorbital lines. Improvement of neck skin laxity and skin texture, were manifested by radiant skin, smaller pores and general volume increase”.

OxyGeneo– A new facial technology providing a 3-in-1 Super Facial treatment: exfoliation, infusion, and oxygenation. The OxyGeneo treatment is now offered at select Four Season spas.

Pollogen technologies are clinically proven with over 16 articles in peer reviewed journals and is available in 60+ countries and their technologies are cleared by FDA, CE and Canadian MOH. The Company’s premier brands and technologies include: TriPollar®, OxyGeneo®, Hybrid Energy™, VoluDerm™, TriLipo and TriFractional™

The WCD is the world’s oldest continuous international dermatology meeting where the international community of dermatologists meets to discuss breakthrough technologies that are changing the face of beauty in cosmetics and aesthetic medicine, latest findings and leading industry leaders display the most advanced technologies and products.

Pollogen’s CEO, Mr. Amichai Bar-Nir stated: “Pollogen is proud to present its innovative VoluDerm treatment in the 2015 WCD. VoluDerm combines the best aspects of micro-needling and radio frequency in one treatment providing visible results and younger-looking skin. Same as our other Pollogen treatments, it can be done in simple ‘walk in – walk out’ procedures.

About Pollogen

We believe in constantly challenging ourselves to create the most advanced, effective medical aesthetic technologies and solutions.

We believe in thinking differently.

In everything we do, we take a customer-centric approach by making our products user-friendly, safe and convenient. We believe in finding ways to develop technologies that work with the body’s natural mechanisms so beautiful results are generated from within.

Pollogen is the developer and manufacturer of five revolutionary technologies under the industry premier brand names OxyGeneo®, VoluDerm™, Hybrid Energy™, TriPollar®, TriLipo® and TriFractional™. We offer a full line of clinically-proven, safe and effective, non-invasive anti-aging facial and body contouring treatment platforms for a wide range of aesthetic applications. Pollogen provides solutions for professionals in over 60 countries, addressing the specific needs and dynamic changes unique to the ever-evolving aesthetic industry







Related Natural Cosmetics Press Releases